• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5%咪喹莫特乳膏治疗后婴儿血管瘤的消退

Involution of infantile haemangiomas after imiquimod 5% cream.

作者信息

Barry R B M, Hughes B R, Cook L J

机构信息

Portsmouth Dermatology Centre, St Mary's Hospital, Portsmouth, Hampshire, UK.

出版信息

Clin Exp Dermatol. 2008 Jul;33(4):446-9. doi: 10.1111/j.1365-2230.2007.02676.x. Epub 2008 May 15.

DOI:10.1111/j.1365-2230.2007.02676.x
PMID:18485022
Abstract

Infantile haemangioma is a common childhood condition, which usually resolves spontaneously and is managed expectantly. In a small percentage of complex cases, haemangiomas may be associated with complications such as persistent bleeding, ulceration, feeding difficulties or visual impairment. Active treatment is often necessary in such cases. Current interventions include surgical, laser and immunomodulatory treatments. Imiquimod 5% cream is a novel alternative topical treatment that may have a potential role in management of these patients. We present our experience of imiquimod 5% cream in the treatment of five children with difficult haemangiomas. We discuss its efficacy and some of the side effects that may be encountered, which have not previously been reported.

摘要

婴儿血管瘤是一种常见的儿童疾病,通常会自行消退,一般采取观察等待的处理方式。在一小部分复杂病例中,血管瘤可能会伴有持续出血、溃疡、喂养困难或视力损害等并发症。在这种情况下,往往需要积极治疗。目前的干预措施包括手术、激光和免疫调节治疗。5%咪喹莫特乳膏是一种新型的局部替代治疗方法,可能在这些患者的治疗中发挥潜在作用。我们介绍了使用5%咪喹莫特乳膏治疗5例难治性血管瘤患儿的经验。我们讨论了其疗效以及可能遇到的一些副作用,这些副作用此前尚未见报道。

相似文献

1
Involution of infantile haemangiomas after imiquimod 5% cream.5%咪喹莫特乳膏治疗后婴儿血管瘤的消退
Clin Exp Dermatol. 2008 Jul;33(4):446-9. doi: 10.1111/j.1365-2230.2007.02676.x. Epub 2008 May 15.
2
Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.外用咪喹莫特治疗婴幼儿血管瘤:一项回顾性研究。
J Am Acad Dermatol. 2007 Jan;56(1):63-8. doi: 10.1016/j.jaad.2006.06.011.
3
Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.咪喹莫特 5%乳膏与噻吗洛尔 0.5%滴眼液治疗浅表增殖性婴幼儿血管瘤:回顾性研究。
Clin Exp Dermatol. 2013 Dec;38(8):845-50. doi: 10.1111/ced.12150. Epub 2013 Apr 30.
4
Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars.用5%咪喹莫特乳膏局部治疗婴幼儿草莓状血管瘤会引起严重的局部反应和毁容性瘢痕。
Pediatr Dermatol. 2013 May-Jun;30(3):342-7. doi: 10.1111/pde.12002. Epub 2012 Oct 9.
5
A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.一项关于5%咪喹莫特乳膏治疗婴幼儿血管瘤的前瞻性自身对照II期研究。
Pediatr Dermatol. 2011 May-Jun;28(3):259-66. doi: 10.1111/j.1525-1470.2011.01520.x.
6
Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.5%咪喹莫特乳膏短期应用治疗婴幼儿血管瘤
J Am Acad Dermatol. 2004 Oct;51(4):639-42. doi: 10.1016/j.jaad.2004.04.022.
7
The role of imiquimod in treating infantile haemangiomas: cause for concern?咪喹莫特在治疗婴幼儿血管瘤中的作用:值得关注吗?
Clin Exp Dermatol. 2009 Oct;34(7):e257. doi: 10.1111/j.1365-2230.2008.03151.x. Epub 2009 Apr 9.
8
Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
Ear Nose Throat J. 2010 Mar;89(3):E21-5.
9
Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.婴儿增殖性血管瘤:外用5%咪喹莫特乳膏治疗成功
Pediatr Dermatol. 2005 May-Jun;22(3):254-6. doi: 10.1111/j.1525-1470.2005.22318.x.
10
Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.局部应用5%咪喹莫特乳膏成功治疗原位恶性黑色素瘤。
Int J Dermatol. 2005 May;44(5):428-34. doi: 10.1111/j.1365-4632.2005.02582.x.

引用本文的文献

1
Japanese clinical practice guidelines for vascular anomalies 2017.2017 年日本血管异常临床实践指南。
Jpn J Radiol. 2020 Apr;38(4):287-342. doi: 10.1007/s11604-019-00885-5.
2
Japanese clinical practice guidelines for vascular anomalies 2017.《2017年日本血管异常临床实践指南》
Pediatr Int. 2020 Mar;62(3):257-304. doi: 10.1111/ped.14077. Epub 2020 Mar 22.
3
Japanese Clinical Practice Guidelines for Vascular Anomalies 2017.日本 2017 年血管异常临床实践指南
J Dermatol. 2020 May;47(5):e138-e183. doi: 10.1111/1346-8138.15189. Epub 2020 Mar 22.
4
Pulsed dye laser and topical timolol gel versus pulse dye laser in treatment of infantile hemangioma: A double-blind randomized controlled trial.脉冲染料激光联合局部噻吗洛尔凝胶与脉冲染料激光治疗婴幼儿血管瘤的双盲随机对照试验
Adv Biomed Res. 2015 Nov 30;4:257. doi: 10.4103/2277-9175.170682. eCollection 2015.
5
A practical guide to treatment of infantile hemangiomas of the head and neck.头颈部婴幼儿血管瘤治疗实用指南
Int J Clin Exp Med. 2013 Oct 25;6(10):851-60. eCollection 2013.
6
Propranolol intervention therapy for infants with facial hemangioma.普萘洛尔干预治疗婴儿面部血管瘤。
Contemp Oncol (Pozn). 2012;16(5):432-4. doi: 10.5114/wo.2012.31774. Epub 2012 Nov 20.
7
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.研究观察:美国食品和药物管理局批准的用于癌症治疗的 Toll 样受体激动剂。
Oncoimmunology. 2012 Sep 1;1(6):894-907. doi: 10.4161/onci.20931.
8
Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety.局部咪喹莫特治疗小儿皮肤血管疾病:疗效和安全性的临床评价。
J Zhejiang Univ Sci B. 2012 Sep;13(9):745-50. doi: 10.1631/jzus.B1200120.
9
Cutaneous lesions of the nose.鼻部皮肤损害。
Head Face Med. 2010 Jun 4;6:7. doi: 10.1186/1746-160X-6-7.